by admin | Feb 26, 2018 | Synvisc One
Last December, Sanofi Genzyme recalled 12,380 Synvisc-One syringes from lot number 7RSL021 sold nationwide in 36 states from October 25, 2017, through November 7, 2017, due to microbial contamination. Now, through a Class 2 recall, the company has revealed the... by michael | Jan 30, 2018 | Synvisc One
There is a possible Synvisc-One lawsuit in the not-so-distant future. In December 2017, Sanofi Genzyme voluntarily recalled Synvisc-One, because of microbial contamination of lot number 7RSL021 sold in 36 U.S. states from October 25, 2017, through November 7, 2017.... by michael | Jan 29, 2018 | Synvisc One
Attention osteoarthritis injection users: there has been a Synvisc-One recall. In December 2017, Sanofi Genzyme voluntarily recalled Synvisc-One. This is a result of microbial contamination of lot number 7RSL021 sold in 36 U.S. states from October 25, 2017, through... by michael | Jan 9, 2018 | Synvisc One
Manufacturer Sanofi Genzyme voluntarily recalled a lot of almost 20,000 Synvisc-One knee injection syringes when discovered that they tested positive for microbial contamination. This lot, number 7RSL021, was sold in the United States from October 25, 2017,... by michael | Jan 2, 2018 | Synvisc One
Millions of people across the United States suffer from constant pain from arthritis. Consumers depend on arthritis medications like Actemra or Synvisc-One to help them lead a normal life. However, these medications aren’t completely safe. When their safety fails,... by michael | Dec 27, 2017 | Synvisc One
In December 2017, Sanofi Genzyme voluntarily recalled Synvisc-One, as a result of an airborne microbial contamination of lot number 7RSL021 sold in the United States from October 25, 2017, through November 7, 2017. This recalled lot equates to over 12,000 syringes....
Recent Comments